Rocket Pharmaceuticals (RCKT) Earnings Date, Estimates & Call Transcripts → Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad) Free RCKT Stock Alerts $23.66 +0.28 (+1.20%) (As of 05/15/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 8EstimatedActual EPS (May. 6) -$0.66 Beat By $0.01 Consensus EPS (May. 6) -$0.67 Get Rocket Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for RCKT and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRCKT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RCKT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsThis is the best new way to score with AIIf you thought that you missed your chance to score big on AI, I have great news. A rare second profit window is starting to open.Click now for the best way into the newest AI projects Rocket Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.70)($0.49)($0.60)Q2 20242($0.71)($0.69)($0.70)Q3 20242($0.73)($0.43)($0.58)Q4 20242($0.70)$0.08($0.31)FY 20248($2.84)($1.53)($2.19)Q1 20251($0.49)($0.49)($0.49)Q2 20251($0.36)($0.36)($0.36)Q3 20251($0.34)($0.34)($0.34)Q4 20251($0.25)($0.25)($0.25)FY 20254($1.44)($1.44)($1.44)RCKT Earnings Date and InformationRocket Pharmaceuticals last announced its earnings results on May 6th, 2024. The biotechnology company reported ($0.66) EPS for the quarter, beating analysts' consensus estimates of ($0.67) by $0.01. Rocket Pharmaceuticals has generated ($2.87) earnings per share over the last year (($2.87) diluted earnings per share). Earnings for Rocket Pharmaceuticals are expected to grow in the coming year, from ($2.85) to ($1.87) per share. Rocket Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.Read More Rocket Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/8/2024Estimated)------- 5/6/2024Q1 2024($0.67)($0.66)+$0.01($0.66)--2/26/2024Q4 2023($0.78)($0.64)+$0.14($0.64)--11/6/2023Q3 2023($0.81)($0.75)+$0.06($0.75)--8/10/2023Q2 2023($0.81)($0.82)($0.01)($0.82)--5/4/2023Q1 2023($0.84)($0.73)+$0.11($0.73)--2/27/2023Q4 2022($0.82)($0.92)($0.10)($0.92)-- Get the Latest News and Ratings for RCKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rocket Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/3/2022Q3 2022($0.77)($0.87)($0.10)($0.87)--8/8/2022Q2 2022($0.68)($0.83)($0.15)($0.83)--5/5/2022Q1 2022($0.70)($0.67)+$0.03($0.67)--2/24/2022Q4 2021($0.75)($0.69)+$0.06($0.69)-- 11/3/2021Q3 2021($0.60)($0.79)($0.19)($0.79)--8/9/2021Q2 2021($0.66)($0.55)+$0.11($0.55)-- Rocket Pharmaceuticals Earnings - Frequently Asked Questions When is Rocket Pharmaceuticals's earnings date? Rocket Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on RCKT's earnings history. Did Rocket Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Rocket Pharmaceuticals (NASDAQ:RCKT) reported ($0.66) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.67) by $0.01. Learn more on analysts' earnings estimate vs. RCKT's actual earnings. How much profit does Rocket Pharmaceuticals generate each year? Rocket Pharmaceuticals (NASDAQ:RCKT) has a recorded net income of -$245.60 million. RCKT has generated -$2.87 earnings per share over the last four quarters. What is Rocket Pharmaceuticals's EPS forecast for next year? Rocket Pharmaceuticals's earnings are expected to grow from ($2.85) per share to ($1.87) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Keros Therapeutics Earnings Results Deciphera Pharmaceuticals Earnings Results Ardelyx Earnings Results Amphastar Pharmaceuticals Earnings Results Amneal Pharmaceuticals Earnings Results Maravai LifeSciences Earnings Results Edgewise Therapeutics Earnings Results Syndax Pharmaceuticals Earnings Results Dyne Therapeutics Earnings Results Geron Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong Earnings This page (NASDAQ:RCKT) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.